This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Solu-Medrone (methylprednisolone sodium succinate) United Kingdom (UK)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

United Kingdom

  • Solu-Medrone (methylprednisolone sodium succinate) 40mg powder for injection - PI for UK
  • Solu-Medrone (methylprednisolone sodium succinate) 125mg powder for injection - PI for UK 
  • Solu-Medrone (methylprednisolone sodium succinate) 500mg powder for injection- PI for UK
  • Solu-Medrone (methylprednisolone sodium succinate) 1g powder for injection- PI for UK

Solu-Medrone (methylprednisolone sodium succinate) 40mg powder for injection - PI for UK

Solu-Medrone (methylprednisolone sodium succinate) 125mg powder for injection - PI for UK 

Solu-Medrone (methylprednisolone sodium succinate) 500mg powder for injection- PI for UK

Solu-Medrone (methylprednisolone sodium succinate) 1g powder for injection- PI for UK

PP-SLM-GBR-0004 March 2022